Emergency Management of Anaphylaxis Due to an Unknown Trigger: An 8-Year Follow-Up Study in Canada

J Allergy Clin Immunol Pract. 2019 Apr;7(4):1166-1173.e1. doi: 10.1016/j.jaip.2018.11.015. Epub 2018 Nov 23.

Abstract

Background: Anaphylaxis due to unknown trigger (AUT) is anaphylaxis not explained by a proved or presumptive cause or stimulus at the time of the reaction. Research describing the management and follow-up of AUT is limited.

Objective: To assess and compare the demographic and clinical characteristics and the management of adult and pediatric AUT cases across Canada.

Methods: Participants were identified between 2011 and 2018 in emergency departments at 8 centers across Canada as part of the Cross-Canada Anaphylaxis Registry. A standardized form documenting the reaction and management in children and adults was completed. Patients were contacted for follow-up to determine assessment by an allergist.

Results: A total of 295 AUT cases (7.5%) were recruited among 3,922 cases of anaphylaxis. In the prehospital setting, children (adjusted odds ratio [aOR], 1.20; 95% CI, 1.05-1.37) and those with a known food allergy (aOR, 1.14; 95% CI, 1.02-1.28) were more likely to receive treatment with epinephrine. Children were also more likely to be assessed by an allergist after their reaction (aOR, 1.43; 95% CI, 1.13-1.81) and were more likely to have an identified trigger for their reaction (aOR, 1.35; 95% CI, 1.07-1.70). Among patients contacted for follow-up, food was identified as the cause of reaction in 11 of 76 patients. A new food allergy was diagnosed in 4 patients (2 children and 2 adults).

Conclusions: Our findings highlight important differences between management and follow-up of adult and pediatric AUT cases. It is crucial to follow up all cases of AUT and establish appropriate treatment and management guidelines.

Keywords: Epidemiology in Canada; Idiopathic anaphylaxis; Management; Treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-Agonists / therapeutic use
  • Adult
  • Aftercare
  • Age Factors
  • Allergy and Immunology
  • Anaphylaxis / epidemiology
  • Anaphylaxis / etiology
  • Anaphylaxis / metabolism
  • Anaphylaxis / therapy*
  • Asthma / epidemiology
  • Canada / epidemiology
  • Child
  • Child, Preschool
  • Comorbidity
  • Emergency Medical Services
  • Emergency Service, Hospital
  • Epinephrine / therapeutic use*
  • Female
  • Fluid Therapy
  • Follow-Up Studies
  • Food Hypersensitivity / complications
  • Food Hypersensitivity / diagnosis*
  • Food Hypersensitivity / epidemiology
  • Histamine Antagonists / therapeutic use*
  • Humans
  • Infant
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Referral and Consultation
  • Registries
  • Skin Tests
  • Sympathomimetics / therapeutic use*
  • Tryptases / metabolism
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-Agonists
  • Histamine Antagonists
  • Sympathomimetics
  • Tryptases
  • Epinephrine